Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: CNS Drugs. 2012 Aug 1;26(8):707–716. doi: 10.2165/11634260-000000000-00000

Table I.

Study sample and source population demographics

Characteristic Study sample
Population
N = 616
N = 6782
n % n %
Sex (female) 406 65.9 5048 74.4
Race
 White 547 88.8 5765 85.0
 Hispanic 41 6.7 632 9.3
 Native American 16 2.6 154 2.3
 African-American 10 1.6 182 2.7
 Other 2 0.3 49 0.7
Diagnoses
 Epilepsy 255 41.4 1188 17.5
 Bipolar disorder 196 31.8 4401 64.9
 Depression 99 16.1 1916 28.3
 Migraine 112 18.2 1406 20.7
 Neuropathic pain 17 2.8 137 2.0
 Other pain 182 29.5 2303 34.0
Age (mean [SD], years) 35.6 [15.5] 34.37 [14.27]
Treatment length (mean [SD], months) 32.8 [4.2] 10.93 [12.19]